Dec 10, 2024 | Legal Compliance
The Corporate Transparency Act (CTA) represents a significant effort to curb financial crimes such as terrorist financing, drug trafficking, and money laundering. By requiring companies to disclose their beneficial ownership information, the CTA aims to close...
Dec 7, 2024 | Legal Compliance, State-Specific Regulations
As the calendar turns to 2025, employers and employees in New York must navigate significant changes in employment laws. These updates aim to promote fairness, enhance workplace safety, and ensure compliance with evolving standards. Below is a comprehensive overview...
Dec 4, 2024 | Legal Compliance
The weight-loss medication market has been experiencing seismic shifts, with pharmaceutical giants Eli Lilly and Novo Nordisk leading the charge. Recent clinical trial results have added more heat to this competition: Lilly’s Zepbound outperformed Novo’s Wegovy in a...
Dec 4, 2024 | Legal Compliance
Semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, is poised to reshape the pharmaceutical and wellness industries as its molecule patent approaches expiration in 2025. While this development is exciting, utility and formulation patents...
Nov 8, 2024 | Legal Compliance, Risk Management
In today’s healthcare industry, rising medication costs and global access to treatment options have led many patients to explore importing medications for personal use or bringing necessary prescriptions when traveling internationally. However, understanding the U.S....
Nov 8, 2024 | Legal Compliance
With the 2024 presidential election behind us and Donald Trump securing his second term, healthcare businesses now face the prospect of significant policy shifts. Given his past healthcare initiatives and campaign promises, Trump’s administration is expected to drive...
